Cargando…

Public Perspectives on COVID-19 Vaccine Prioritization

IMPORTANCE: As COVID-19 vaccine distribution continues, policy makers are struggling to decide which groups should be prioritized for vaccination. OBJECTIVE: To assess US adults’ preferences regarding COVID-19 vaccine prioritization. DESIGN, SETTING, AND PARTICIPANTS: This survey study involved 2 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Persad, Govind, Emanuel, Ezekiel J., Sangenito, Samantha, Glickman, Aaron, Phillips, Steven, Largent, Emily A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035644/
https://www.ncbi.nlm.nih.gov/pubmed/33835172
http://dx.doi.org/10.1001/jamanetworkopen.2021.7943
_version_ 1783676743230423040
author Persad, Govind
Emanuel, Ezekiel J.
Sangenito, Samantha
Glickman, Aaron
Phillips, Steven
Largent, Emily A.
author_facet Persad, Govind
Emanuel, Ezekiel J.
Sangenito, Samantha
Glickman, Aaron
Phillips, Steven
Largent, Emily A.
author_sort Persad, Govind
collection PubMed
description IMPORTANCE: As COVID-19 vaccine distribution continues, policy makers are struggling to decide which groups should be prioritized for vaccination. OBJECTIVE: To assess US adults’ preferences regarding COVID-19 vaccine prioritization. DESIGN, SETTING, AND PARTICIPANTS: This survey study involved 2 independent, online surveys of US adults aged 18 years and older, 1 conducted by Gallup from September 14 to 27, 2020, and the other conducted by the COVID Collaborative from September 19 to 25, 2020. Samples were weighted to reflect sociodemographic characteristics of the US population. EXPOSURES: Respondents were asked to prioritize groups for COVID-19 vaccine and to rank their prioritization considerations. MAIN OUTCOMES AND MEASURES: The study assessed prioritization preferences and agreement with the National Academies of Science, Engineering, and Medicine’s Preliminary Framework for Equitable Allocation of COVID-19 Vaccine. RESULTS: A total of 4735 individuals participated, 2730 (1474 men [54.1%]; mean [SD] age, 59.2 [14.5] years) in the Gallup survey and 2005 (944 men [47.1%]; 203 participants [21.5%] aged 55-59 years) in the COVID Collaborative survey. In both the Gallup COVID-19 Panel and COVID Collaborative surveys, respondents listed health care workers (Gallup, 93.6% [95% CI, 91.2%-95.3%]; COVID Collaborative, 80.0% [95% CI, 78.0%-81.9%]) and adults of any age with serious comorbid conditions (Gallup, 78.6% [95% CI, 75.2%-81.7%]; COVID Collaborative, 72.9% [95% CI, 70.7%-74.9%]) among their 4 highest priority groups. Respondents of all political affiliations agreed with prioritizing Black, Hispanic, Native American, and other communities that have been disproportionately affected by COVID-19 (Gallup, 74.2% [95% CI, 70.6%-77.5%]; COVID Collaborative, 84.9% [95% CI, 83.1%-86.5%]), and COVID Collaborative respondents were willing to be preceded in line by teachers and childcare workers (92.5%; 95% CI, 91.2%-93.7%) and grocery workers (85.9%; 95% CI, 84.2%-87.5%). Older respondents in both surveys were significantly less likely than younger respondents to prioritize healthy adults aged 65 years and older among their 4 highest priority groups (Gallup, 23.7% vs 39.1% [χ(2) = 2160.8; P < .001]; COVID Collaborative, 23.3% vs 28.8% [χ(2) = 5.0198; P = .03]). COVID Collaborative respondents believed the 4 most important considerations for prioritization were preventing COVID-19 spread (78.4% [95% CI, 76.3%-80.3%]), preventing the most deaths (72.1% [95% CI, 69.9%-74.2%]), preventing long-term complications (68.9% [66.6%-71.9%]), and protecting frontline workers (63.8% [95% CI, 61.5%-66.1%]). CONCLUSIONS AND RELEVANCE: US adults broadly agreed with the National Academies of Science, Engineering, and Medicine’s prioritization framework. Respondents endorsed prioritizing racial/ethnic communities that are disproportionately affected by COVID-19, and older respondents were significantly less likely than younger respondents to endorse prioritizing healthy people older than 65 years. This provides reason for caution about COVID-19 vaccine distribution plans that prioritize healthy adults older than a cutoff age without including those younger than that age with preexisting conditions, that aim solely to prevent the most deaths, or that give no priority to frontline workers or disproportionately affected communities.
format Online
Article
Text
id pubmed-8035644
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-80356442021-04-27 Public Perspectives on COVID-19 Vaccine Prioritization Persad, Govind Emanuel, Ezekiel J. Sangenito, Samantha Glickman, Aaron Phillips, Steven Largent, Emily A. JAMA Netw Open Original Investigation IMPORTANCE: As COVID-19 vaccine distribution continues, policy makers are struggling to decide which groups should be prioritized for vaccination. OBJECTIVE: To assess US adults’ preferences regarding COVID-19 vaccine prioritization. DESIGN, SETTING, AND PARTICIPANTS: This survey study involved 2 independent, online surveys of US adults aged 18 years and older, 1 conducted by Gallup from September 14 to 27, 2020, and the other conducted by the COVID Collaborative from September 19 to 25, 2020. Samples were weighted to reflect sociodemographic characteristics of the US population. EXPOSURES: Respondents were asked to prioritize groups for COVID-19 vaccine and to rank their prioritization considerations. MAIN OUTCOMES AND MEASURES: The study assessed prioritization preferences and agreement with the National Academies of Science, Engineering, and Medicine’s Preliminary Framework for Equitable Allocation of COVID-19 Vaccine. RESULTS: A total of 4735 individuals participated, 2730 (1474 men [54.1%]; mean [SD] age, 59.2 [14.5] years) in the Gallup survey and 2005 (944 men [47.1%]; 203 participants [21.5%] aged 55-59 years) in the COVID Collaborative survey. In both the Gallup COVID-19 Panel and COVID Collaborative surveys, respondents listed health care workers (Gallup, 93.6% [95% CI, 91.2%-95.3%]; COVID Collaborative, 80.0% [95% CI, 78.0%-81.9%]) and adults of any age with serious comorbid conditions (Gallup, 78.6% [95% CI, 75.2%-81.7%]; COVID Collaborative, 72.9% [95% CI, 70.7%-74.9%]) among their 4 highest priority groups. Respondents of all political affiliations agreed with prioritizing Black, Hispanic, Native American, and other communities that have been disproportionately affected by COVID-19 (Gallup, 74.2% [95% CI, 70.6%-77.5%]; COVID Collaborative, 84.9% [95% CI, 83.1%-86.5%]), and COVID Collaborative respondents were willing to be preceded in line by teachers and childcare workers (92.5%; 95% CI, 91.2%-93.7%) and grocery workers (85.9%; 95% CI, 84.2%-87.5%). Older respondents in both surveys were significantly less likely than younger respondents to prioritize healthy adults aged 65 years and older among their 4 highest priority groups (Gallup, 23.7% vs 39.1% [χ(2) = 2160.8; P < .001]; COVID Collaborative, 23.3% vs 28.8% [χ(2) = 5.0198; P = .03]). COVID Collaborative respondents believed the 4 most important considerations for prioritization were preventing COVID-19 spread (78.4% [95% CI, 76.3%-80.3%]), preventing the most deaths (72.1% [95% CI, 69.9%-74.2%]), preventing long-term complications (68.9% [66.6%-71.9%]), and protecting frontline workers (63.8% [95% CI, 61.5%-66.1%]). CONCLUSIONS AND RELEVANCE: US adults broadly agreed with the National Academies of Science, Engineering, and Medicine’s prioritization framework. Respondents endorsed prioritizing racial/ethnic communities that are disproportionately affected by COVID-19, and older respondents were significantly less likely than younger respondents to endorse prioritizing healthy people older than 65 years. This provides reason for caution about COVID-19 vaccine distribution plans that prioritize healthy adults older than a cutoff age without including those younger than that age with preexisting conditions, that aim solely to prevent the most deaths, or that give no priority to frontline workers or disproportionately affected communities. American Medical Association 2021-04-09 /pmc/articles/PMC8035644/ /pubmed/33835172 http://dx.doi.org/10.1001/jamanetworkopen.2021.7943 Text en Copyright 2021 Persad G et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Persad, Govind
Emanuel, Ezekiel J.
Sangenito, Samantha
Glickman, Aaron
Phillips, Steven
Largent, Emily A.
Public Perspectives on COVID-19 Vaccine Prioritization
title Public Perspectives on COVID-19 Vaccine Prioritization
title_full Public Perspectives on COVID-19 Vaccine Prioritization
title_fullStr Public Perspectives on COVID-19 Vaccine Prioritization
title_full_unstemmed Public Perspectives on COVID-19 Vaccine Prioritization
title_short Public Perspectives on COVID-19 Vaccine Prioritization
title_sort public perspectives on covid-19 vaccine prioritization
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035644/
https://www.ncbi.nlm.nih.gov/pubmed/33835172
http://dx.doi.org/10.1001/jamanetworkopen.2021.7943
work_keys_str_mv AT persadgovind publicperspectivesoncovid19vaccineprioritization
AT emanuelezekielj publicperspectivesoncovid19vaccineprioritization
AT sangenitosamantha publicperspectivesoncovid19vaccineprioritization
AT glickmanaaron publicperspectivesoncovid19vaccineprioritization
AT phillipssteven publicperspectivesoncovid19vaccineprioritization
AT largentemilya publicperspectivesoncovid19vaccineprioritization